Clinical Trials Directory

Trials / Completed

CompletedNCT03770156

Terrorist Attack - Continuity of Care

Attentats - Continuité Des Soins

Status
Completed
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

On November 13th 2015, a terrorist attack killed 129 victims in Paris. An emergency crisis unit (CUMP) has been activated in Paris in the days following the attack and a subunit was in charge to answer to the phone calls of victims and their relatives. The same emergency crisis unit have been activated for the terrorist attack in London, 2017 june 3, terrorist attack in Barcelone 2017 august 17-18, terrorist attack in Strasbourg 2018 December 11 The purpose of this observational study is to document the evolution of psychiatric symptoms among subjects who called the CUMP and to collect information about the type of medical or non-medical care they were seeking for.

Detailed description

The care of the victims of natural disasters or mass disasters such as terrorist attacks is now better structured and organized. The efficacy of debriefing or of defusing has been and is still debated, sometimes bitterly. The aim of the present study is not to demonstrate utility or futility of such approaches, but to i) evaluate their global improvement over the past three years. ii) to list the type of support that the victims were seeking in their attempt to get rid of the symptoms which appeared after the terrorist attack of November 2015 in Paris. iii) to collect their opinions about the way the CUMP (emergency medico-psychological unit of Paris, France) managed the support to the victims. Participating subjects registered on the occasion of their first contact with the CUMP 75 by phone during the week following the attack

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuestionnairesOverall Impression of the current state and evolution since the attacks

Timeline

Start date
2020-01-22
Primary completion
2020-10-22
Completion
2020-10-22
First posted
2018-12-10
Last updated
2025-09-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03770156. Inclusion in this directory is not an endorsement.